{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T09:42:24Z","timestamp":1762854144498,"version":"build-2065373602"},"reference-count":10,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,19]],"date-time":"2020-01-19T00:00:00Z","timestamp":1579392000000},"content-version":"am","delay-in-days":383,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.gofs.2018.11.006","type":"journal-article","created":{"date-parts":[[2018,11,28]],"date-time":"2018-11-28T00:33:00Z","timestamp":1543365180000},"page":"79-81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comment je fais\u2026 l\u2019injection intrad\u00e9trusorienne de toxine botulinique pour traiter l\u2019hyperactivit\u00e9 v\u00e9sicale"],"prefix":"10.1016","volume":"47","author":[{"given":"E.","family":"Cerruto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Lamblin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Vernier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Lebail-Carval","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Chabert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Mellier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Chene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2014","series-title":"Commission de la transparence du 23\u00a0juillet 2014 (CT-13729) Botox (toxine botulinique A)","key":"10.1016\/j.gofs.2018.11.006_bib0055"},{"key":"10.1016\/j.gofs.2018.11.006_bib0060","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00345-017-2121-6","article-title":"The effect of onabotulinumtoxin A according to site of injection in patients with overactive bladder: a systematic review and meta-analysis","volume":"36","author":"Jo","year":"2018","journal-title":"World J Urol"},{"key":"10.1016\/j.gofs.2018.11.006_bib0065","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1007\/s11255-015-1125-7","article-title":"The safety and efficiency of onabotulinumtoxin A for the treatment of overactive bladder: a systematic review and meta-analysis","volume":"47","author":"Sun","year":"2015","journal-title":"Int Urol Nephrol"},{"year":"2016","series-title":"EAU Guidelines on urinary incontinence in adults","author":"Burkhard","key":"10.1016\/j.gofs.2018.11.006_bib0070"},{"year":"2017","series-title":"Commission de transparence \u2014\u00a0HAS du 11\u00a0octobre 2017","key":"10.1016\/j.gofs.2018.11.006_bib0075"},{"key":"10.1016\/j.gofs.2018.11.006_bib0080","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.jgyn.2014.06.011","article-title":"Intra-detrusor injection of botulinum toxin for female refractory idiopathic overactive bladder syndrome","volume":"43","author":"Deffieux","year":"2014","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"key":"10.1016\/j.gofs.2018.11.006_bib0085","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1016\/j.juro.2012.12.022","article-title":"EMBARK Study Group. Onabotulinumtoxin A for the treatment of patients with overactive bladder and urinary incontinence: results of a phase 3, randomized, placebo controlled trial","volume":"189","author":"Nitti","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.gofs.2018.11.006_bib0090","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1016\/j.juro.2010.08.021","article-title":"Efficacy and safety of onabotulinumtoxinA for idiopathic overactive bladder: a double-blind, placebo controlled, randomized, dose ranging trial","volume":"184","author":"Dmochowski","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.gofs.2018.11.006_bib0095","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.purol.2014.06.005","article-title":"Guidelines for practical usage of botulinum toxin type A (BoNTA) for refractory idiopathic overactive bladder management: translation of French recommendations","volume":"24","author":"Hermieu","year":"2014","journal-title":"Prog Urol"},{"key":"10.1016\/j.gofs.2018.11.006_bib0100","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/bju.13945","article-title":"Comparative assessment of the efficacy of onabotulinumtoxin A and oral therapies (anticholinergics and mirabegron) for overactive bladder: a systematic review and network meta-analysis","volume":"120","author":"Drake","year":"2017","journal-title":"BJU Int"}],"container-title":["Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468718918303234?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468718918303234?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T09:37:27Z","timestamp":1762853847000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468718918303234"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S2468718918303234"],"URL":"https:\/\/doi.org\/10.1016\/j.gofs.2018.11.006","relation":{},"ISSN":["2468-7189"],"issn-type":[{"type":"print","value":"2468-7189"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comment je fais\u2026 l\u2019injection intrad\u00e9trusorienne de toxine botulinique pour traiter l\u2019hyperactivit\u00e9 v\u00e9sicale","name":"articletitle","label":"Article Title"},{"value":"Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gofs.2018.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}